AT:IMM Immutep Limited

Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.This company has ADRs that trade in the U.S. as the symbol IMMP.

0.33 AUD
As of 11/25/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Australia
Country of incorporation:  Australia
IPO date:  01/01/1900
Stock exchange:    Asx - All Markets
Exchange country:   Australia
Market cap:   337,378,592 AUD
Current dividend yield:   0.00%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy